Indication and outcome of late open conversion after abdominal endovascular aortic repair.
Options
BORIS DOI
Publisher DOI
PubMed ID
38810725
Description
OBJECTIVE
Endovascular aortic repair (EVAR) has become the standard of care for patients with infrarenal aortic aneurysms over the last two decades. Endograft technology and treatment of complications like endoleaks, graft migration or graft occlusion developed over time. However, sometimes open surgical conversion maybe required. Our aim was to analyze the indications, the technical aspects and outcomes in patients who underwent open conversion after EVAR with different types and generations of endografts.
METHODS
This retrospective single-center study reviewed all patients who underwent EVAR from 2004 to 2020. Open surgical conversions > 1 month post EVAR were identified. Conversions for graft infection were excluded. Indications for conversion and operative technique were analyzed. Primary endpoint of the study was 30-day mortality. Secondary endpoints were re-interventions and follow up mortality.
RESULTS
During 2004 and 2020, 443 consecutive EVARs were performed, and 28 patients required open surgical conversion, with an additional 3 referred from other hospitals (N=31). The median age was 75 (range 58-93); 94% were male. Conversion was performed after a median time of 55 months (range 16 - 209). Twenty patients underwent elective and 11 emergency conversion. Indications for open conversion were graft migration respectively disease progression with endoleak type Ia and/ or Ib in 52 % (16/31) and sac expansion due to endoleak type II in 26 % (8/31). Of the 31 patients, 17 (55%) had at least one previous endovascular re-intervention. All patients met the device-specific instructions for use for each implanted endograft. In-hospital intervention rate was 16 % (5/31). 30-day mortality rate was 3% (1/31) with one patient died due to multi-organ failure after rupture with complete endograft replacement. Five patients (16%) died during follow-up. Mid-term follow-up was 47.5 months (range 24 -203) with estimated cumulative survival rates of 97%, 89%, and 84%, at 1, 3, and 5 years, respectively.
CONCLUSION
Late open conversion remains a valuable treatment option and can be performed safely in elective and emergency setting with a low early mortality. Lifelong surveillance, and prompt intervention when necessary are essential in ensuring optimal outcomes after EVAR and preventing the need for emergent conversions.
Endovascular aortic repair (EVAR) has become the standard of care for patients with infrarenal aortic aneurysms over the last two decades. Endograft technology and treatment of complications like endoleaks, graft migration or graft occlusion developed over time. However, sometimes open surgical conversion maybe required. Our aim was to analyze the indications, the technical aspects and outcomes in patients who underwent open conversion after EVAR with different types and generations of endografts.
METHODS
This retrospective single-center study reviewed all patients who underwent EVAR from 2004 to 2020. Open surgical conversions > 1 month post EVAR were identified. Conversions for graft infection were excluded. Indications for conversion and operative technique were analyzed. Primary endpoint of the study was 30-day mortality. Secondary endpoints were re-interventions and follow up mortality.
RESULTS
During 2004 and 2020, 443 consecutive EVARs were performed, and 28 patients required open surgical conversion, with an additional 3 referred from other hospitals (N=31). The median age was 75 (range 58-93); 94% were male. Conversion was performed after a median time of 55 months (range 16 - 209). Twenty patients underwent elective and 11 emergency conversion. Indications for open conversion were graft migration respectively disease progression with endoleak type Ia and/ or Ib in 52 % (16/31) and sac expansion due to endoleak type II in 26 % (8/31). Of the 31 patients, 17 (55%) had at least one previous endovascular re-intervention. All patients met the device-specific instructions for use for each implanted endograft. In-hospital intervention rate was 16 % (5/31). 30-day mortality rate was 3% (1/31) with one patient died due to multi-organ failure after rupture with complete endograft replacement. Five patients (16%) died during follow-up. Mid-term follow-up was 47.5 months (range 24 -203) with estimated cumulative survival rates of 97%, 89%, and 84%, at 1, 3, and 5 years, respectively.
CONCLUSION
Late open conversion remains a valuable treatment option and can be performed safely in elective and emergency setting with a low early mortality. Lifelong surveillance, and prompt intervention when necessary are essential in ensuring optimal outcomes after EVAR and preventing the need for emergent conversions.
Date of Publication
2024-09
Publication Type
Article
Subject(s)
Keyword(s)
EVAR Endoleaks late open conversion rupture
Language(s)
en
Contributor(s)
Additional Credits
Series
Annals of vascular surgery
Publisher
Elsevier
ISSN
1615-5947
Access(Rights)
open.access